Alastair Kent
Cell and Gene Therapy Catapult(GB)
Publications by Year
Research Areas
Genomics and Rare Diseases, Biomedical Ethics and Regulation, BRCA gene mutations in cancer, Health Systems, Economic Evaluations, Quality of Life, Science, Research, and Medicine
Most-Cited Works
- → Correction: Corrigendum: TCTEX1D2 mutations underlie Jeune asphyxiating thoracic dystrophy with impaired retrograde intraflagellar transport(2016)259 cited
- → Marketing of unproven stem cell–based interventions: A call to action(2017)196 cited
- → Genetic education and the challenge of genomic medicine: development of core competences to support preparation of health professionals in Europe(2010)170 cited
- → A Pilot Study of Multicriteria Decision Analysis for Valuing Orphan Medicines(2013)109 cited
- → TCTEX1D2 mutations underlie Jeune asphyxiating thoracic dystrophy with impaired retrograde intraflagellar transport(2015)81 cited
- → Ethical review of research into rare genetic disorders(2004)44 cited
- → GENERATING HEALTH TECHNOLOGY ASSESSMENT EVIDENCE FOR RARE DISEASES(2014)43 cited
- → Prevention of Congenital Disorders and Care of Affected Children(2016)42 cited
- → Managing clinically significant findings in research: the UK10K example(2014)42 cited
- → European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care(2017)40 cited